Report Detail
Global PVA Embolization Particles Market Insights, Forecast to 2025
- RnM3358018 |
- 27 April, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
The global PVA Embolization Particles market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the PVA Embolization Particles market based on company, product type, end user and key regions.
This report studies the global market size of PVA Embolization Particles in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of PVA Embolization Particles in these regions.
This research report categorizes the global PVA Embolization Particles market by top players/brands, region, type and end user. This report also studies the global PVA Embolization Particles market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials
Alicon
Market size by Product
Conventional/Irregular PVA
Compressible and Spherical PVA
Market size by End User
Uterine Fibroid Embolization
Prostatic Artery Embolization
Liver Tumor Embolization
Trauma Embolization
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global PVA Embolization Particles market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of PVA Embolization Particles market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global PVA Embolization Particles companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of PVA Embolization Particles submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of PVA Embolization Particles are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of PVA Embolization Particles market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 PVA Embolization Particles Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global PVA Embolization Particles Market Size Growth Rate by Product
- 1.4.2 Conventional/Irregular PVA
- 1.4.3 Compressible and Spherical PVA
- 1.5 Market by End User
- 1.5.1 Global PVA Embolization Particles Market Size Growth Rate by End User
- 1.5.2 Uterine Fibroid Embolization
- 1.5.3 Prostatic Artery Embolization
- 1.5.4 Liver Tumor Embolization
- 1.5.5 Trauma Embolization
- 1.5.6 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global PVA Embolization Particles Market Size
- 2.1.1 Global PVA Embolization Particles Revenue 2014-2025
- 2.1.2 Global PVA Embolization Particles Sales 2014-2025
- 2.2 PVA Embolization Particles Growth Rate by Regions
- 2.2.1 Global PVA Embolization Particles Sales by Regions
- 2.2.2 Global PVA Embolization Particles Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 PVA Embolization Particles Sales by Manufacturers
- 3.1.1 PVA Embolization Particles Sales by Manufacturers
- 3.1.2 PVA Embolization Particles Sales Market Share by Manufacturers
- 3.1.3 Global PVA Embolization Particles Market Concentration Ratio (CR5 and HHI)
- 3.2 PVA Embolization Particles Revenue by Manufacturers
- 3.2.1 PVA Embolization Particles Revenue by Manufacturers (2014-2019)
- 3.2.2 PVA Embolization Particles Revenue Share by Manufacturers (2014-2019)
- 3.3 PVA Embolization Particles Price by Manufacturers
- 3.4 PVA Embolization Particles Manufacturing Base Distribution, Product Types
- 3.4.1 PVA Embolization Particles Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers PVA Embolization Particles Product Type
- 3.4.3 Date of International Manufacturers Enter into PVA Embolization Particles Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global PVA Embolization Particles Sales by Product
- 4.2 Global PVA Embolization Particles Revenue by Product
- 4.3 PVA Embolization Particles Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global PVA Embolization Particles Breakdown Data by End User
6 North America
- 6.1 North America PVA Embolization Particles by Countries
- 6.1.1 North America PVA Embolization Particles Sales by Countries
- 6.1.2 North America PVA Embolization Particles Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America PVA Embolization Particles by Product
- 6.3 North America PVA Embolization Particles by End User
7 Europe
- 7.1 Europe PVA Embolization Particles by Countries
- 7.1.1 Europe PVA Embolization Particles Sales by Countries
- 7.1.2 Europe PVA Embolization Particles Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe PVA Embolization Particles by Product
- 7.3 Europe PVA Embolization Particles by End User
8 Asia Pacific
- 8.1 Asia Pacific PVA Embolization Particles by Countries
- 8.1.1 Asia Pacific PVA Embolization Particles Sales by Countries
- 8.1.2 Asia Pacific PVA Embolization Particles Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific PVA Embolization Particles by Product
- 8.3 Asia Pacific PVA Embolization Particles by End User
9 Central & South America
- 9.1 Central & South America PVA Embolization Particles by Countries
- 9.1.1 Central & South America PVA Embolization Particles Sales by Countries
- 9.1.2 Central & South America PVA Embolization Particles Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America PVA Embolization Particles by Product
- 9.3 Central & South America PVA Embolization Particles by End User
10 Middle East and Africa
- 10.1 Middle East and Africa PVA Embolization Particles by Countries
- 10.1.1 Middle East and Africa PVA Embolization Particles Sales by Countries
- 10.1.2 Middle East and Africa PVA Embolization Particles Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa PVA Embolization Particles by Product
- 10.3 Middle East and Africa PVA Embolization Particles by End User
11 Company Profiles
- 11.1 Sirtex Medical
- 11.1.1 Sirtex Medical Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sirtex Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sirtex Medical PVA Embolization Particles Products Offered
- 11.1.5 Sirtex Medical Recent Development
- 11.2 Merit Medical
- 11.2.1 Merit Medical Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merit Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merit Medical PVA Embolization Particles Products Offered
- 11.2.5 Merit Medical Recent Development
- 11.3 Cook Medical
- 11.3.1 Cook Medical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Cook Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Cook Medical PVA Embolization Particles Products Offered
- 11.3.5 Cook Medical Recent Development
- 11.4 BTG Medical
- 11.4.1 BTG Medical Company Details
- 11.4.2 Company Business Overview
- 11.4.3 BTG Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 BTG Medical PVA Embolization Particles Products Offered
- 11.4.5 BTG Medical Recent Development
- 11.5 Boston Scientific Corporation
- 11.5.1 Boston Scientific Corporation Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Boston Scientific Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Boston Scientific Corporation PVA Embolization Particles Products Offered
- 11.5.5 Boston Scientific Corporation Recent Development
- 11.6 Terumo Corporation
- 11.6.1 Terumo Corporation Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Terumo Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Terumo Corporation PVA Embolization Particles Products Offered
- 11.6.5 Terumo Corporation Recent Development
- 11.7 HENGRUI Medical
- 11.7.1 HENGRUI Medical Company Details
- 11.7.2 Company Business Overview
- 11.7.3 HENGRUI Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 HENGRUI Medical PVA Embolization Particles Products Offered
- 11.7.5 HENGRUI Medical Recent Development
- 11.8 INterface BIOmaterials
- 11.8.1 INterface BIOmaterials Company Details
- 11.8.2 Company Business Overview
- 11.8.3 INterface BIOmaterials PVA Embolization Particles Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 INterface BIOmaterials PVA Embolization Particles Products Offered
- 11.8.5 INterface BIOmaterials Recent Development
- 11.9 Alicon
- 11.9.1 Alicon Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Alicon PVA Embolization Particles Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Alicon PVA Embolization Particles Products Offered
- 11.9.5 Alicon Recent Development
12 Future Forecast
- 12.1 PVA Embolization Particles Market Forecast by Regions
- 12.1.1 Global PVA Embolization Particles Sales Forecast by Regions 2019-2025
- 12.1.2 Global PVA Embolization Particles Revenue Forecast by Regions 2019-2025
- 12.2 PVA Embolization Particles Market Forecast by Product
- 12.2.1 Global PVA Embolization Particles Sales Forecast by Product 2019-2025
- 12.2.2 Global PVA Embolization Particles Revenue Forecast by Product 2019-2025
- 12.3 PVA Embolization Particles Market Forecast by End User
- 12.4 North America PVA Embolization Particles Forecast
- 12.5 Europe PVA Embolization Particles Forecast
- 12.6 Asia Pacific PVA Embolization Particles Forecast
- 12.7 Central & South America PVA Embolization Particles Forecast
- 12.8 Middle East and Africa PVA Embolization Particles Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 PVA Embolization Particles Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on PVA Embolization Particles. Industry analysis & Market Report on PVA Embolization Particles is a syndicated market report, published as Global PVA Embolization Particles Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of PVA Embolization Particles market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
